HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amrita Ahluwalia Selected Research

de- Gln(18)- de- Ser(19)- de- Gly(20,22)- de- Leu(21)- atrial natriuretic factor (4-23)NH2

9/2004Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amrita Ahluwalia Research Topics

Disease

12Hypoxia (Hypoxemia)
01/2021 - 02/2007
12Inflammation (Inflammations)
01/2021 - 06/2008
9Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 03/2008
8Ulcer
01/2021 - 01/2013
8Myocardial Infarction
10/2019 - 01/2015
8Infarction (Infarctions)
01/2019 - 09/2004
8Reperfusion Injury
01/2017 - 03/2002
7ST Elevation Myocardial Infarction
01/2021 - 01/2015
7Hypertension (High Blood Pressure)
01/2020 - 11/2004
5Myocardial Ischemia (Ischemic Heart Diseases)
09/2007 - 03/2002
4Neoplasms (Cancer)
10/2017 - 08/2013
4Ulcerative Colitis
10/2015 - 03/2009
3COVID-19
01/2022 - 11/2021
3Heart Diseases (Heart Disease)
09/2021 - 12/2016
3Stomach Ulcer (Gastric Ulcer)
01/2021 - 01/2013
3Heart Failure
01/2019 - 10/2017
3Stroke (Strokes)
11/2018 - 08/2010
3Atherosclerosis
01/2016 - 10/2009
3Ischemia
02/2007 - 09/2004
2Blister (Bulla)
01/2022 - 01/2017
2Vascular Diseases (Vascular Disease)
01/2021 - 11/2004
2Sepsis (Septicemia)
01/2018 - 02/2005
2Atherosclerotic Plaque (Atheroma)
01/2017 - 11/2009
2Hypercholesterolemia
01/2016 - 08/2010
2Acidosis
08/2015 - 10/2008
2Duodenal Ulcer (Curling's Ulcer)
02/2014 - 11/2011
2Colonic Neoplasms (Colon Cancer)
01/2014 - 08/2013
2Hypotension (Low Blood Pressure)
10/2012 - 02/2005
2Colitis
01/2012 - 03/2009
1Cardiomegaly (Heart Hypertrophy)
10/2022
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
10/2022
1Fibrosis (Cirrhosis)
10/2022
1Infections
01/2022
1Neurogenic Inflammation
01/2022
1Skin Diseases (Skin Disease)
01/2022
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2021
1Cicatrix (Scar)
01/2021
1Acute Coronary Syndrome
01/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2021
1Arthritis (Polyarthritis)
11/2018

Drug/Important Bio-Agent (IBA)

13NitritesIBA
10/2022 - 09/2004
13NitratesIBA
10/2022 - 03/2008
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 03/2009
10Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2018 - 09/2004
7Xanthine DehydrogenaseIBA
10/2022 - 09/2004
7Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2007
4Sodium NitriteIBA
10/2019 - 02/2007
4Karyopherins (Importin)IBA
11/2018 - 02/2014
4Messenger RNA (mRNA)IBA
10/2016 - 03/2009
4Nitrite Reductases (Nitrite Reductase)IBA
08/2015 - 02/2007
4ProstaglandinsIBA
12/2014 - 01/2013
4Transcription Factors (Transcription Factor)IBA
04/2014 - 12/2007
320-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
01/2022 - 08/2013
3Nerve Growth Factor (NGF)IBA
01/2021 - 01/2018
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2019 - 04/2014
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2018 - 04/2014
3SurvivinIBA
11/2018 - 12/2007
3Shiga Toxin (Shigella Toxin)IBA
01/2018 - 01/2012
3Pharmaceutical PreparationsIBA
01/2017 - 05/2013
3Oxygen (Dioxygen)IBA
12/2014 - 01/2014
2Cantharidin (Cantharides)IBA
01/2022 - 01/2017
2LipidsIBA
01/2022 - 01/2018
2LigandsIBA
01/2022 - 01/2018
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 01/2014
2Biological ProductsIBA
01/2021 - 01/2021
2Caspase 9IBA
11/2018 - 12/2007
2Caspase 3 (Caspase-3)IBA
11/2018 - 12/2007
2Mitogen-Activated Protein KinasesIBA
01/2018 - 01/2016
2Peptides (Polypeptides)IBA
10/2017 - 06/2007
2CytokinesIBA
01/2017 - 02/2014
2ChemokinesIBA
01/2017 - 03/2013
2IodoacetamideIBA
10/2015 - 03/2009
2TensinsIBA
12/2014 - 12/2007
2Ethanol (Ethyl Alcohol)IBA
12/2014 - 04/2014
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2014 - 12/2007
2Vasodilator Agents (Vasodilators)IBA
05/2013 - 02/2005
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
06/2012 - 10/2008
2Gonadal Steroid Hormones (Sex Hormones)IBA
05/2011 - 06/2008
2KininsIBA
11/2009 - 04/2009
2C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA
10/2005 - 09/2004
2endothelium-dependent hyperpolarization factor (EDHF)IBA
02/2005 - 03/2002
1Superoxides (Superoxide)IBA
10/2022
1molnupiravirIBA
01/2022
1nirmatrelvir and ritonavir drug combinationIBA
01/2022
1Arachidonic Acid (Vitamin F)IBA
01/2022
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2022
1Angiotensin Receptor AntagonistsIBA
01/2022
112-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA
01/2022
1NeuropeptidesIBA
01/2022
1Transient Receptor Potential ChannelsIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
11/2021
1Contrast MediaIBA
01/2021
1Complementary DNA (cDNA)IBA
01/2021
1AngiopoietinsIBA
01/2021
1Diclofenac (SR 38)FDA LinkGeneric
02/2019

Therapy/Procedure

10Therapeutics
01/2022 - 11/2004
10Percutaneous Coronary Intervention
01/2021 - 01/2015
2Patient Readmission
10/2017 - 10/2017
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
09/2021
1Myocardial Revascularization
01/2019